Novel Spiroisatin Derivatives Potentially Useful for Preventing Myocardial Reperfusion Injury
Year: 2026
Type: article
Abstract: Ischemia−reperfusion injury remains a major clinical challenge due to mitochondrial dysfunction and cell death. Here we report a novel series of spiroisatin derivatives as modulators of the mitochondrial permeability transition pore (mPTP) targeted at the c-ring of F1/FO-ATP synthase. Structure−activity relationship analysis identified compound 15j with nanomolar in vitro potency in inhibiting mPTP opening while preserving ATP production. Molecular modeling supported distinct binding interactions within the c subunit of F1/FO-ATP synthase, rationalizing observed pharmacodynamics. Beyond mPTP inhibition, 15j positively modulates mitochondrial quality control pathways, including mitophagy and biogenesis, contributing to sustained mitochondrial homeostasis after reperfusion. These findings establish spiroisatin derivatives as a promising class of cardioprotective agents acting through convergent mechanisms on mitochondrial integrity and quality control.
Source: Journal of Medicinal Chemistry
Authors: Valentina Albanese, Gaia Pedriali, Elena Nicoletta Colarusso, Sandro Cosconati, Michele Roggia, Ali Mohammad Shaukat, Tiziano De Ventura, Martina Fabbri, Lorenzo Tagliazucchi, Carlotta Giorgi, Remo Guerrini, Sara Leo, Elena Tremoli, Giampaolo Morciano, Delia Preti, Paolo Pinton, Salvatore Pacifico
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,500
OpenAlex ID: W7235255846
